Department of Military Affairs Tender by Indian Army (GEM/2025/B/6092584)
HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100IU/ML (RECOMBINANT DNA ORIGIN) 300IU DISPOSABLE PEN WITH

Tender Timeline
Tender Title: Human Insulin Analogue Rapid Acting Injection 100IU/mL (Recombinant DNA Origin) 300IU Disposable Pen
Reference Number: GEM/2025/B/6092584
Issuing Authority/Department
The Human Insulin Analogue Tender is issued by the Department of Military Affairs, which operates under the Ministry of Defence. This tender aims to procure essential medical supplies essential for maintaining healthcare standards for military personnel.
Scope of Work and Objectives
The objective of this tender is to solicit bids for the supply of Human Insulin Analogue Rapid Acting Injection, specifically in 100IU/mL concentration delivered in 300IU disposable pens. The total quantity required under this tender is 7500 units. Bidders are expected to deliver high-quality products aligned with medical standards to meet the healthcare demands of military agencies efficiently.
Eligibility Criteria
To participate in this tender, bidders must fulfill certain eligibility requirements. Organizations must be legally registered entities capable of handling pharmaceutical supplies. Moreover, suppliers must demonstrate a history of compliance with health and safety standards relevant to pharmaceutical products and should have the capability to deliver the specified quantity within agreed timelines.
Technical Requirements
The technical specifications for the Human Insulin Analogue include:
- Must be 100IU/mL concentration.
- Supplied in 300IU disposable pens.
- Products must comply with the latest pharmacological guidelines set forth by authorized health organizations.
Bidders should provide detailed documentation proving the product's adherence to relevant quality standards and specifications.
Financial Requirements
Bidders must submit a complete financial proposal that may include the Earnest Money Deposit (EMD), which safeguards the interests of the contracting authority. Pricing must be competitive yet reflect the quality of the product offered.
Document Submission Details
All necessary documents must be submitted electronically through the designated online portal. Bidders are advised to ensure that all submissions are complete and comply with the prescribed formats to avoid disqualification.
Special Provisions
The tender may include provisions aimed at benefiting Micro, Small, and Medium Enterprises (MSEs), allowing them to participate more actively in government contracts. There are specific support measures available for startups, fostering innovation and competition within the industry.
Evaluation Process
Proposals will undergo a comprehensive evaluation process that entails both technical and financial assessments. Criteria will focus on the completeness of submissions, product quality, compliance with technical specifications, and competitive pricing. Successful bidders will be those whose proposals best meet the high standards set by the Ministry of Defence.
Delivery Locations
Successful bidders will be required to deliver the products to specified military health facilities as directed in subsequent communication post-award. Logistics for delivery must be coordinated effectively to ensure timely receipt of the insulin injections.
Contact Information
For any inquiries related to the tender, potential bidders can reach out via the official channels outlined in the portal. Ensure clear communication for prompt responses to urgent questions or concerns.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsDocuments Required from Seller
- Past Performance
- Bidder Turnover
- OEM Authorization Certificate
- Additional Doc 2 (Requested in ATC)
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a recognized and registered entity capable of supplying pharmaceutical products. Bidders must also provide proof of compliance with health and safety regulations pertinent to pharmaceutical supplies. A track record in the delivery of similar products may be advantageous in assessing eligibility.
The technical specifications for the Human Insulin Analogue Rapid Acting Injection include a concentration of 100IU/mL in 300IU disposable pens. Compliance with all relevant pharmacological guidelines is mandatory. Bidders must also submit documents confirming that their products meet these specifications.
Bidders are required to provide a complete financial proposal that incorporates the Earnest Money Deposit (EMD) as part of their bid submission. The EMD serves as a security measure to protect the interests of the contracting authority. Payment terms and buyer considerations will be clarified upon tender acceptance.
Documents must be submitted electronically on the designated online platform. Bidders must ensure that their submissions are complete and adhere to the specified format requirements to avoid disqualification. It is crucial for bidders to review submission guidelines carefully.
Provisions for Micro, Small, and Medium Enterprises (MSEs) and startups are incorporated to encourage the participation of smaller organizations in government contracts. These provisions aim to promote innovation while ensuring competitive pricing and product quality aligned with national procurement policies.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders